Selected research
Industry Research
Epilepsy Devices Industry Research Report 2026
Market perspective
The global Epilepsy Devices market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Epilepsy Devices is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Epilepsy Devices is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Epilepsy Devices is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Epilepsy Devices include Medtronic, Nihon Kohden Corporation, Neuropace, Natus Medical Incorporated, Medpage, MC10, Liva Nova, Koninklijke Philips and Jude Medical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Epilepsy Devices market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Epilepsy Devices Market by Company
Medtronic
Nihon Kohden Corporation
Neuropace
Natus Medical Incorporated
Medpage
MC10
Liva Nova
Koninklijke Philips
Jude Medical
Empatica
Compumedics
Cerbomed
Boston Scientific Corporation
Epilepsy Devices Segment by Type
Conventional Devices
Wearable Devices
Implantable Devices
Epilepsy Devices Segment by Application
Hospitals
Neurology Centers
Others
Epilepsy Devices Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Epilepsy Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Epilepsy Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Epilepsy Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Epilepsy Devices manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Epilepsy Devices by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Epilepsy Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Conventional Devices
- Wearable Devices
- Implantable Devices
Applications
- Hospitals
- Neurology Centers
- Others
Companies covered
- Medtronic
- Nihon Kohden Corporation
- Neuropace
- Natus Medical Incorporated
- Medpage
- MC10
- Liva Nova
- Koninklijke Philips
- Jude Medical
- Empatica
- Compumedics
- Cerbomed
- Boston Scientific Corporation
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Epilepsy Devices Market Size (2021-2032)
- 2.2.2 Global Epilepsy Devices Sales (2021-2032)
- 2.2.3 Global Epilepsy Devices Market Average Price (2021-2032)
- 2.3 Epilepsy Devices by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Conventional Devices
- 2.3.3 Wearable Devices
- 2.3.4 Implantable Devices
- 2.4 Epilepsy Devices by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Neurology Centers
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Epilepsy Devices Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Epilepsy Devices Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Epilepsy Devices Revenue of Manufacturers (2021-2026)
- 3.4 Global Epilepsy Devices Average Price by Manufacturers (2021-2026)
- 3.5 Global Epilepsy Devices Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Epilepsy Devices, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Epilepsy Devices, Product Type & Application
- 3.8 Global Manufacturers of Epilepsy Devices, Established Date
- 3.9 Global Epilepsy Devices Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Medtronic
- 4.1.1 Medtronic Company Information
- 4.1.2 Medtronic Business Overview
- 4.1.3 Medtronic Epilepsy Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Medtronic Epilepsy Devices Product Portfolio
- 4.1.5 Medtronic Recent Developments
- 4.2 Nihon Kohden Corporation
- 4.2.1 Nihon Kohden Corporation Company Information
- 4.2.2 Nihon Kohden Corporation Business Overview
- 4.2.3 Nihon Kohden Corporation Epilepsy Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Nihon Kohden Corporation Epilepsy Devices Product Portfolio
- 4.2.5 Nihon Kohden Corporation Recent Developments
- 4.3 Neuropace
- 4.3.1 Neuropace Company Information
- 4.3.2 Neuropace Business Overview
- 4.3.3 Neuropace Epilepsy Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Neuropace Epilepsy Devices Product Portfolio
- 4.3.5 Neuropace Recent Developments
- 4.4 Natus Medical Incorporated
- 4.4.1 Natus Medical Incorporated Company Information
- 4.4.2 Natus Medical Incorporated Business Overview
- 4.4.3 Natus Medical Incorporated Epilepsy Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Natus Medical Incorporated Epilepsy Devices Product Portfolio
- 4.4.5 Natus Medical Incorporated Recent Developments
- 4.5 Medpage
- 4.5.1 Medpage Company Information
- 4.5.2 Medpage Business Overview
- 4.5.3 Medpage Epilepsy Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Medpage Epilepsy Devices Product Portfolio
- 4.5.5 Medpage Recent Developments
- 4.6 MC10
- 4.6.1 MC10 Company Information
- 4.6.2 MC10 Business Overview
- 4.6.3 MC10 Epilepsy Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 MC10 Epilepsy Devices Product Portfolio
- 4.6.5 MC10 Recent Developments
- 4.7 Liva Nova
- 4.7.1 Liva Nova Company Information
- 4.7.2 Liva Nova Business Overview
- 4.7.3 Liva Nova Epilepsy Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Liva Nova Epilepsy Devices Product Portfolio
- 4.7.5 Liva Nova Recent Developments
- 4.8 Koninklijke Philips
- 4.8.1 Koninklijke Philips Company Information
- 4.8.2 Koninklijke Philips Business Overview
- 4.8.3 Koninklijke Philips Epilepsy Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Koninklijke Philips Epilepsy Devices Product Portfolio
- 4.8.5 Koninklijke Philips Recent Developments
- 4.9 Jude Medical
- 4.9.1 Jude Medical Company Information
- 4.9.2 Jude Medical Business Overview
- 4.9.3 Jude Medical Epilepsy Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Jude Medical Epilepsy Devices Product Portfolio
- 4.9.5 Jude Medical Recent Developments
- 4.10 Empatica
- 4.10.1 Empatica Company Information
- 4.10.2 Empatica Business Overview
- 4.10.3 Empatica Epilepsy Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Empatica Epilepsy Devices Product Portfolio
- 4.10.5 Empatica Recent Developments
- 4.11 Compumedics
- 4.11.1 Compumedics Company Information
- 4.11.2 Compumedics Business Overview
- 4.11.3 Compumedics Epilepsy Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Compumedics Epilepsy Devices Product Portfolio
- 4.11.5 Compumedics Recent Developments
- 4.12 Cerbomed
- 4.12.1 Cerbomed Company Information
- 4.12.2 Cerbomed Business Overview
- 4.12.3 Cerbomed Epilepsy Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Cerbomed Epilepsy Devices Product Portfolio
- 4.12.5 Cerbomed Recent Developments
- 4.13 Boston Scientific Corporation
- 4.13.1 Boston Scientific Corporation Company Information
- 4.13.2 Boston Scientific Corporation Business Overview
- 4.13.3 Boston Scientific Corporation Epilepsy Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Boston Scientific Corporation Epilepsy Devices Product Portfolio
- 4.13.5 Boston Scientific Corporation Recent Developments
5 Global Epilepsy Devices Market Scenario by Region
- 5.1 Global Epilepsy Devices Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Epilepsy Devices Sales by Region: 2021-2032
- 5.2.1 Global Epilepsy Devices Sales by Region: 2021-2026
- 5.2.2 Global Epilepsy Devices Sales by Region: 2027-2032
- 5.3 Global Epilepsy Devices Revenue by Region: 2021-2032
- 5.3.1 Global Epilepsy Devices Revenue by Region: 2021-2026
- 5.3.2 Global Epilepsy Devices Revenue by Region: 2027-2032
- 5.4 North America Epilepsy Devices Market Facts & Figures by Country
- 5.4.1 North America Epilepsy Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Epilepsy Devices Sales by Country (2021-2032)
- 5.4.3 North America Epilepsy Devices Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Epilepsy Devices Market Facts & Figures by Country
- 5.5.1 Europe Epilepsy Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Epilepsy Devices Sales by Country (2021-2032)
- 5.5.3 Europe Epilepsy Devices Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Epilepsy Devices Market Facts & Figures by Country
- 5.6.1 Asia Pacific Epilepsy Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Epilepsy Devices Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Epilepsy Devices Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Epilepsy Devices Market Facts & Figures by Country
- 5.7.1 South America Epilepsy Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Epilepsy Devices Sales by Country (2021-2032)
- 5.7.3 South America Epilepsy Devices Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Epilepsy Devices Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Epilepsy Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Epilepsy Devices Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Epilepsy Devices Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Epilepsy Devices Sales by Type (2021-2032)
- 6.1.1 Global Epilepsy Devices Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Epilepsy Devices Sales Market Share by Type (2021-2032)
- 6.2 Global Epilepsy Devices Revenue by Type (2021-2032)
- 6.2.1 Global Epilepsy Devices Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Epilepsy Devices Revenue Market Share by Type (2021-2032)
- 6.3 Global Epilepsy Devices Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Epilepsy Devices Sales by Application (2021-2032)
- 7.1.1 Global Epilepsy Devices Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Epilepsy Devices Sales Market Share by Application (2021-2032)
- 7.2 Global Epilepsy Devices Revenue by Application (2021-2032)
- 7.2.1 Global Epilepsy Devices Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Epilepsy Devices Revenue Market Share by Application (2021-2032)
- 7.3 Global Epilepsy Devices Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Epilepsy Devices Value Chain Analysis
- 8.1.1 Epilepsy Devices Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Epilepsy Devices Production Mode & Process
- 8.2 Epilepsy Devices Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Epilepsy Devices Distributors
- 8.2.3 Epilepsy Devices Customers
9 Global Epilepsy Devices Analyzing Market Dynamics
- 9.1 Epilepsy Devices Industry Trends
- 9.2 Epilepsy Devices Industry Drivers
- 9.3 Epilepsy Devices Industry Opportunities and Challenges
- 9.4 Epilepsy Devices Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst